Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis O Eko

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Human Vaccines|April 3, 2008
Development of a Chlamydia trachomatis bacterial ghost vaccine to fight human blindnessFrancis O Eko, Barisani Asenbauer Talin, Werner Lubitz
Expert Review of Vaccines|August 7, 2003
Bacterial ghosts as carrier and targeting systems for mucosal antigen deliveryKatri Jalava, Francis O Eko, Eva Riedmann, et al.
Expert Review of Vaccines|November 3, 2011
Chlamydia vaccines: recent developments and the role of adjuvants in future formulationsJoseph U Igietseme, Francis O Eko, Carolyn M Black
Expert Review of Vaccines|August 7, 2003
Contemporary approaches to designing and evaluating vaccines against ChlamydiaJoseph U Igietseme, Francis O Eko, Carolyn M Black
Biotechnology Letters|November 17, 2007
Exploiting cholera vaccines as a versatile antigen delivery platformAnisia J Silva, Francis O Eko, Jorge A Benitez
Expert Review of Vaccines|December 23, 2006
Combination vaccines: design strategies and future trendsJoseph U Igietseme, Francis O Eko, Qing He, et al.
Expert Review of Vaccines|February 6, 2004
Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogensJoseph U Igietseme, Francis O Eko, Qing He, et al.
Frontiers in Immunology|July 24, 2019
Route of Vaccine Administration Influences the Impact of Fms-Like Tyrosine Kinase 3 Ligand (Flt3L) on Chlamydial-Specific Protective Immune ResponsesRoshan Pais, Yusuf Omosun, Joseph U Igietseme, et al.
Biomedicines|February 26, 2025
A VCG-Based Multiepitope <i>Chlamydia</i> Vaccine Incorporating the Cholera Toxin A1 Subunit (MECA) Confers Protective Immunity Against Transcervical ChallengeFnu Medhavi, Tayhlor Tanner, Shakyra Richardson, et al.
Current Opinion in Molecular Therapeutics|June 16, 2004
Developing effective delivery systems for Chlamydia vaccinesJoseph U Igietseme, Francis O Eko, Qing He, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Human Vaccines|April 3, 2008
Development of a Chlamydia trachomatis bacterial ghost vaccine to fight human blindnessFrancis O Eko, Barisani Asenbauer Talin, Werner Lubitz
Expert Review of Vaccines|August 7, 2003
Bacterial ghosts as carrier and targeting systems for mucosal antigen deliveryKatri Jalava, Francis O Eko, Eva Riedmann, et al.
Expert Review of Vaccines|November 3, 2011
Chlamydia vaccines: recent developments and the role of adjuvants in future formulationsJoseph U Igietseme, Francis O Eko, Carolyn M Black
Expert Review of Vaccines|August 7, 2003
Contemporary approaches to designing and evaluating vaccines against ChlamydiaJoseph U Igietseme, Francis O Eko, Carolyn M Black
Biotechnology Letters|November 17, 2007
Exploiting cholera vaccines as a versatile antigen delivery platformAnisia J Silva, Francis O Eko, Jorge A Benitez
Expert Review of Vaccines|December 23, 2006
Combination vaccines: design strategies and future trendsJoseph U Igietseme, Francis O Eko, Qing He, et al.
Expert Review of Vaccines|February 6, 2004
Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogensJoseph U Igietseme, Francis O Eko, Qing He, et al.
Frontiers in Immunology|July 24, 2019
Route of Vaccine Administration Influences the Impact of Fms-Like Tyrosine Kinase 3 Ligand (Flt3L) on Chlamydial-Specific Protective Immune ResponsesRoshan Pais, Yusuf Omosun, Joseph U Igietseme, et al.
Biomedicines|February 26, 2025
A VCG-Based Multiepitope <i>Chlamydia</i> Vaccine Incorporating the Cholera Toxin A1 Subunit (MECA) Confers Protective Immunity Against Transcervical ChallengeFnu Medhavi, Tayhlor Tanner, Shakyra Richardson, et al.
Current Opinion in Molecular Therapeutics|June 16, 2004
Developing effective delivery systems for Chlamydia vaccinesJoseph U Igietseme, Francis O Eko, Qing He, et al.
Pageof 6